The Digital Medicine Society (DiMe) announced today a new collaboration with Acclinate, Amgen, GSK, Lightship, Medable, Rubix LS, Sage Bionetworks, Savvy Cooperative, and THREAD Research to drive inclusion in digital clinical trials. The initiative aims to provide the tools and framework necessary to successfully integrate diverse perspectives during the planning process for trials that include a technology device for participation.
When people ask me about what I do as a software engineer, they often expect me to talk about lines of code, algorithms, or frameworks. Those things m...
At Acclinate, signed contracts aren’t finish lines. They’re the starting point of successful partnerships. Our sales and customer success teams work h...
Too often in clinical research, pharma companies “helicopter in” to a community when enrollment targets loom, only to disappear once the trial ends. C...
“Data is the new oil.” It’s a phrase we hear often, and in many ways, it’s true. In clinical research, every interaction—from a patient’s electronic h...
At its core, clinical research is about advancing treatments that change lives—for individuals, families, and entire communities. But those treatments...
Key Takeaways and Learnings Long-term relationship building delivers measurable results. Culturally responsive research practices require representati...
Key Takeaways and Learnings Health tech for inclusive research must be built with representation at the forefront—from design to deployment. Exclusion...
When I think about the role of technology in healthcare, I feel both excited and cautious. Excited, because scaling technology means we can reach more...
Key Takeaways and Learnings The belief that representation slows clinical trials is outdated—early inclusion strategies often speed them up. Retention...
.jpg?width=300&name=64ee7ebf711c42cfdd7beae3_hush-naidoo-jade-photography-pA0uoltkwao-unsplash%20(3).jpg)
